Literature DB >> 25773165

Growth factors and IL-17 in hereditary angioedema.

M Salemi1, V Mandalà2, V Muggeo2, G Misiano3, S Milano3, G Colonna-Romano3, F Arcoleo1, E Cillari4.   

Abstract

Hereditary angioedema (HAE) is a rare autosomal dominant disorder, due to C1-inhibitor deficiency, which causes episodic swellings of subcutaneous tissues, bowel walls and upper airways which are disabling and potentially life-threatening. We evaluated n = 17 patients with confirmed HAE diagnosis in basal and crisis state and n = 19 healthy subjects. The samples were tested for IL-17, FGFb, G-CSF and GM-CSF, using Bio-plex kit. Data analysis was performed via nonparametric Spearman's correlations and two sets of linear mixed models. When comparing HAE subjects during basal and crisis states, we found out significantly (i.e., p value <0.05) higher values in crisis states rather than in basal states for the three growth factors and cytokine IL-17. When comparing healthy subjects versus HAE patients at basal state, we found out significantly higher values in HAE subjects only for GM-CSF, FGFb and IL-17, but not for G-CSF. In HAE patients, there is a connection between IL-17 and growth factors. The low-grade inflammation in absence of attacks is demonstrated by constant higher amount of IL-17, FGFb and GM-CSF with respect to healthy patients. This could indicate that in this disease there is a level of activation that maintains the system in a "tick-over state," that can be activate by several stimuli that are able to induce a increase in inflammatory mediators during the acute attack.

Entities:  

Keywords:  Growth factors; Hereditary angioedema; IL-17

Mesh:

Substances:

Year:  2015        PMID: 25773165     DOI: 10.1007/s10238-015-0340-y

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  19 in total

Review 1.  C1 inhibitor: biologic activities that are independent of protease inhibition.

Authors:  Alvin E Davis; Shenghe Cai; Dongxu Liu
Journal:  Immunobiology       Date:  2006-12-11       Impact factor: 3.144

Review 2.  Keratinocytes and cytokine/growth factors.

Authors:  C Feliciani; A K Gupta; D N Sauder
Journal:  Crit Rev Oral Biol Med       Date:  1996

3.  Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice.

Authors:  S B Forlow; J R Schurr; J K Kolls; G J Bagby; P O Schwarzenberger; K Ley
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

4.  Plasma bradykinin in angio-oedema.

Authors:  J Nussberger; M Cugno; C Amstutz; M Cicardi; A Pellacani; A Agostoni
Journal:  Lancet       Date:  1998-06-06       Impact factor: 79.321

5.  Parameters of the classical complement pathway predict disease severity in hereditary angioedema.

Authors:  Dorottya Csuka; George Füst; Henriette Farkas; Lilian Varga
Journal:  Clin Immunol       Date:  2011-01-20       Impact factor: 3.969

6.  Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.

Authors:  Michael Platten; Sawsan Youssef; Eun Mi Hur; Peggy P Ho; May H Han; Tobias V Lanz; Lori K Phillips; Matthew J Goldstein; Roopa Bhat; Cedric S Raine; Raymond A Sobel; Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-19       Impact factor: 11.205

7.  Evidence for a cross-talk between human neutrophils and Th17 cells.

Authors:  Martin Pelletier; Laura Maggi; Alessandra Micheletti; Elena Lazzeri; Nicola Tamassia; Claudio Costantini; Lorenzo Cosmi; Claudio Lunardi; Francesco Annunziato; Sergio Romagnani; Marco A Cassatella
Journal:  Blood       Date:  2009-11-04       Impact factor: 22.113

8.  Modification of peripheral blood T-lymphocyte surface receptors and Langerhans cell numbers in hereditary angioedema.

Authors:  E Cillari; G Misiano; M Aricò; E La Rocca; D Lio; S di Leonardo; M Brai
Journal:  Am J Clin Pathol       Date:  1986-03       Impact factor: 2.493

Review 9.  Fibroblast growth factors in epithelial repair and cytoprotection.

Authors:  Susanne Braun; Ulrich auf dem Keller; Heike Steiling; Sabine Werner
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-05-29       Impact factor: 6.237

10.  The effect of C1-esterase inhibitor on systemic inflammation in trauma patients with a femur fracture - The CAESAR study: study protocol for a randomized controlled trial.

Authors:  Marjolein Heeres; Tjaakje Visser; Karlijn J P van Wessem; Anky H L Koenderman; Paul F W Strengers; Leo Koenderman; Luke P H Leenen
Journal:  Trials       Date:  2011-10-11       Impact factor: 2.279

View more
  6 in total

1.  The complex alteration in the network of IL-17-type cytokines in patients with hereditary angioedema.

Authors:  Francesco Arcoleo; Mariangela Lo Pizzo; Gabriella Misiano; Salvatore Milano; Giuseppina Colonna Romano; Vito Muggeo; Enrico Cillari
Journal:  Clin Exp Med       Date:  2018-04-06       Impact factor: 3.984

Review 2.  "Nuts and Bolts" of Laboratory Evaluation of Angioedema.

Authors:  Henriette Farkas; Nóra Veszeli; Erika Kajdácsi; László Cervenak; Lilian Varga
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 3.  Genetics of Hereditary Angioedema Revisited.

Authors:  Anastasios E Germenis; Matthaios Speletas
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

4.  Determining biomarkers for evaluation and diagnosis of hereditary angioedema.

Authors:  Umesh Singh; Jonathan A Bernstein
Journal:  Clin Transl Allergy       Date:  2022-10-12       Impact factor: 5.657

Review 5.  Roles of Immune Cells in Hereditary Angioedema.

Authors:  Anne Lise Ferrara; Leonardo Cristinziano; Angelica Petraroli; Maria Bova; Maria Celeste Gigliotti; Simone Marcella; Luca Modestino; Gilda Varricchi; Mariantonia Braile; Maria Rosaria Galdiero; Giuseppe Spadaro; Stefania Loffredo
Journal:  Clin Rev Allergy Immunol       Date:  2021-05-29       Impact factor: 8.667

Review 6.  Biomarkers in Hereditary Angioedema.

Authors:  Grzegorz Porebski; Mateusz Kwitniewski; Avner Reshef
Journal:  Clin Rev Allergy Immunol       Date:  2021-02-09       Impact factor: 8.667

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.